Description
MESALAMINE 800MG, 180 TAB/BT
First action · last action
2022-09-26 · 2023-09-06
Transactions
3
First transaction's obligation
$344,113
Base + all options value (sum of deltas)
$1,032,340
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
10
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-09-26+$344,113= $344,113
- Mod P000012023-03-15+$344,113= $688,226
- Mod P000022023-09-06+$344,113= $1,032,340
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-09-26 | +$344,113 | $344,113 | MESALAMINE 800MG, 180 TAB/BT |
| Mod P00001· EXERCISE AN OPTION | 2023-03-15 | +$344,113 | $688,226 | MESALAMINE 800MG, 180 TAB/BT |
| Mod P00002· EXERCISE AN OPTION | 2023-09-06 | +$344,113 | $1,032,340 | MESALAMINE 800MG, 180 TAB/BT |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CN3LREBPMXJ9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C77026P0117 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $35,862 | FY2026 |
| 36C77026P0094 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $23,379 | FY2026 |
| 36C77026P0090 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $8,028 | FY2026 |
| 36C77026P0071 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $514,928 | FY2026 |
| 36C77026P0065 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $36,432 | FY2026 |
| 36C77026P0036 | NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS | $2,180,332 | FY2026 |
Other recipients under 6505 from NATIONAL CMOP OFFICE (36C770) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C77026P0118 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $30,935 | FY2026 |
| 36C77026P0129 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $76,656 | FY2026 |
| 36C77026P0127 | DERRAH MORRISON ENTERPRISES LLC | NATIONAL CMOP OFFICE (36C770) | $58,395 | FY2026 |
| 36C77026P0086 | SAGENT PHARMACEUTICALS, INC | NATIONAL CMOP OFFICE (36C770) | $275,580 | FY2026 |
| 36C77026P0095 | HYGEN PHARMACEUTICALS INC | NATIONAL CMOP OFFICE (36C770) | $83,520 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C77022P0453_3600_-NONE-_-NONE- · retrieved 2026-09-26.